ABBOTT REALTIME HCV GENOTYPE II

Assay, Genotyping, Hepatitis C Virus

FDA Premarket Approval P120012 S009

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for two changes to the application specification files to extend the chiller delay timer and change the conductivity setting for the detection of rna wash2 liquid.

DeviceABBOTT REALTIME HCV GENOTYPE II
Classification NameAssay, Genotyping, Hepatitis C Virus
Generic NameAssay, Genotyping, Hepatitis C Virus
ApplicantABBOTT MOLECULAR
Date Received2015-07-29
Decision Date2015-10-09
PMAP120012
SupplementS009
Product CodeOBF
Advisory CommitteeMicrobiology
Supplement TypeReal-time Process
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address ABBOTT MOLECULAR 1300 East Touhy Avenue des Plaines, IL 60018

Supplemental Filings

Supplement NumberDateSupplement Type
P120012Original Filing
S019 2021-02-05 30-day Notice
S018 2019-04-10 30-day Notice
S017 2018-05-25 30-day Notice
S016 2017-06-27 135 Review Track For 30-day Notice
S015 2016-12-01 30-day Notice
S014 2016-06-01 30-day Notice
S013 2016-04-20 30-day Notice
S012 2016-03-28 30-day Notice
S011 2016-03-25 30-day Notice
S010 2015-12-16 Real-time Process
S009 2015-07-29 Real-time Process
S008
S007 2015-03-26 30-day Notice
S006 2014-11-10 30-day Notice
S005 2014-10-24 30-day Notice
S004 2014-08-28 30-day Notice
S003 2013-07-23 30-day Notice
S002 2013-07-15 30-day Notice
S001 2013-07-12 30-day Notice

NIH GUDID Devices

Device IDPMASupp
00884999036444 P120012 001
00884999036147 P120012 001
00884999036130 P120012 001
00884999034266 P120012 001
00884999042513 P120012 010

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.